CRISPINUS
ActiveSummary
CRISPINUS has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €124,503 and a net result of €174,904. Equity is shrinking by ~4.9% per year across the filed fiscal years. Its solvency ranks better than 21% of 16810 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100▲+5
Solvency47▲+1
Growth58=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9,000 at 30 days acceptable
Liquidity tight (current ratio 1.06 against 0.96 in 2024; short-term debt: 57.5% and cash: 18.3% of total assets), and 78.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
21.6%
Return on assets
30.4%
Age of the figures
15 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 16810 sector peers (2025).
NBB · sector comparisonPosition among 16810 sector peers
Solvency
better than 21%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 06-01-2026, 25 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
25 d early
2024
3 d early
2023
5 d early
2022
40 d early
2021
41 d early
2020
39 d early
2019
21 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 25 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 6 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-06-2026 close30-09-2026 today31-01-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€124,503=
2024 · €124,503
Total assets
€575,551▼ 2.8%
2024 · €592,017
Net result
€174,904▲ 40.0%
2024 · €124,946
Working capital
€18,354
2024 · -€12,366
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€115,283▲ 71.4%€81,666▼ 29.2%€84,702▲ 3.7%€172,051▲ 103%€241,523▲ 40.4%
Net result€85,471within the sector's middle half▲ 92.7%€57,029within the sector's middle half▼ 33.3%€62,435within the sector's middle half▲ 9.5%€124,946above the sector's middle half▲ 100%€174,904above the sector's middle half▲ 40.0%
Equity€230,365within the sector's middle half▲ 0.2%€211,794within the sector's middle half▼ 8.1%€212,229within the sector's middle half▲ 0.2%€124,503within the sector's middle half▼ 41.3%€124,503within the sector's middle half=
Total assets€454,036within the sector's middle half▼ 4.1%€430,971within the sector's middle half▼ 5.1%€388,630within the sector's middle half▼ 9.8%€592,017within the sector's middle half▲ 52.3%€575,551within the sector's middle half▼ 2.8%
Debt€223,671▼ 8.2%€219,177▼ 2.0%€176,402▼ 19.5%€467,515▲ 165%€451,048▼ 3.5%
Working capital€48,866within the sector's middle half▲ 4.7%€24,447within the sector's middle half▼ 50.0%€40,741within the sector's middle half▲ 66.6%-€12,366below the sector's middle half€18,354within the sector's middle half
Solvency50.7%within the sector's middle half▲ 2.2pp49.1%within the sector's middle half▼ 1.6pp54.6%within the sector's middle half▲ 5.5pp21.0%below the sector's middle half▼ 33.6pp21.6%below the sector's middle half▲ 0.6pp
Current ratio1.28below the sector's middle half▼ 0.011.12below the sector's middle half▼ 0.151.24below the sector's middle half▲ 0.110.96below the sector's middle half▼ 0.281.06below the sector's middle half▲ 0.10
Return on assets (ROA)18.8%within the sector's middle half▲ 9.5pp13.2%within the sector's middle half▼ 5.6pp16.1%within the sector's middle half▲ 2.8pp21.1%within the sector's middle half▲ 5.0pp30.4%within the sector's middle half▲ 9.3pp
Staff (FTE)0.5=2
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 40% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €575,551
Fixed assets
€226,311 ▼ 22.5%
Current assets
€349,240 ▲ 16.3%
Equity and liabilities €575,551
Equity
€124,503 =
Debt
€451,048 ▼ 3.5%
Debt's share of the balance-sheet total falls from 79.0% to 78.4%. Debt is lower.
Key figures and ratios
EBITDA
€312,107▲
2024 · €215,326
Cash flow
€245,488▲
2024 · €168,221
Debt to equity
3.62▼
2024 · 3.76
ROE
140.5%▲
2024 · 100.4%
Interest coverage
33.68▼
2024 · 42.06
Debt ≤ 1 year
€330,886▲
2024 · €312,556
Debt > 1 year
€90,353▼
2024 · €119,472
Income taxes
€57,690▲
2024 · €42,158
Staff costs
€27,236▼
2024 · €28,015
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,713 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 96% are still going.
- Micro
- 5 to 10 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
1.8%
went bankrupt
2.2%
stopped otherwise
96%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,713 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €6,000 | - |
| Remuneration, social security and pensions62 | - | €17,807 | €21,091 | €28,015 | €27,236 | ▼ 2.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €45,581 | €42,495 | €39,611 | €43,275 | €70,584 | ▲ 63.1% |
| Other operating charges640/8 | - | €1,092 | €1,192 | €2,001 | €1,243 | ▼ 37.9% |
| Non-recurring operating charges66A | - | €1,965 | €0 | - | €1,503 | - |
| Gross operating margin9900 | €178,759 | €145,025 | €146,596 | €245,342 | €342,089 | ▲ 39.4% |
| Operating profit (loss)9901 | €115,283 | €81,666 | €84,702 | €172,051 | €241,523 | ▲ 40.4% |
| Financial income75/76B | - | €5 | €0 | €172 | €337 | ▲ 95.3% |
| Recurring financial income75 | €12 | €5 | €0 | €172 | €337 | ▲ 95.3% |
| Financial charges65/66B | - | €3,299 | €4,425 | €5,120 | €9,266 | ▲ 81.0% |
| Recurring financial charges65 | €2,812 | €3,299 | €4,425 | €5,120 | €9,266 | ▲ 81.0% |
| Profit (loss) for the period before taxes9903 | €112,483 | €78,372 | €80,277 | €167,103 | €232,594 | ▲ 39.2% |
| Income taxes67/77 | €27,011 | €21,343 | €17,843 | €42,158 | €57,690 | ▲ 36.8% |
| Profit (loss) for the period9904 | €85,471 | €57,029 | €62,435 | €124,946 | €174,904 | ▲ 40.0% |
| Transfer from tax-exempt reserves789 | - | €18,750 | €0 | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €85,471 | €75,779 | €62,435 | €124,946 | €174,904 | ▲ 40.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €454,036 | €430,971 | €388,630 | €592,017 | €575,551 | ▼ 2.8% |
| Fixed assets21/28 | €228,994 | €207,632 | €175,550 | €291,827 | €226,311 | ▼ 22.5% |
| Intangible fixed assets21 | €55,000 | €45,000 | €35,000 | €25,000 | €15,000 | ▼ 40.0% |
| Tangible fixed assets22/27 | €173,994 | €162,632 | €140,550 | €266,827 | €211,311 | ▼ 20.8% |
| Land and buildings22 | - | €63,860 | €55,781 | €48,289 | €40,960 | ▼ 15.2% |
| Plant, machinery and equipment23 | - | €95,516 | €82,332 | €63,286 | €44,518 | ▼ 29.7% |
| Furniture and vehicles24 | - | €3,256 | €2,438 | €155,252 | €125,833 | ▼ 18.9% |
| Current assets29/58 | €225,042 | €223,340 | €213,080 | €300,190 | €349,240 | ▲ 16.3% |
| Amounts receivable within one year40/41 | €519 | €8,882 | €17,873 | €7,893 | €2,653 | ▼ 66.4% |
| Trade receivables40 | - | €0 | - | - | €294 | - |
| Other amounts receivable41 | - | €8,882 | €17,873 | €7,893 | €2,358 | ▼ 70.1% |
| Current investments50/53 | €6,173 | €17,027 | €27,096 | €31,887 | €36,686 | ▲ 15.1% |
| Cash at bank and in hand54/58 | €78,447 | €70,060 | €39,410 | €13,405 | €105,129 | ▲ 684% |
| Deferred charges and accrued income490/1 | - | €127,370 | €128,701 | €247,005 | €204,772 | ▼ 17.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €454,036 | €430,971 | €388,630 | €592,017 | €575,551 | ▼ 2.8% |
| Equity10/15 | €230,365 | €211,794 | €212,229 | €124,503 | €124,503 | = |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €211,765 | €193,194 | €193,629 | €105,903 | €105,903 | = |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | €0 | - | - |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | €0 | - | - |
| Tax-exempt reserves132 | - | €0 | - | - | - | - |
| Distributable reserves133 | - | €191,334 | €191,769 | €105,903 | €105,903 | = |
| Profit (loss) carried forward14 | - | €0 | €0 | €0 | €0 | - |
| Amounts payable17/49 | €223,671 | €219,177 | €176,402 | €467,515 | €451,048 | ▼ 3.5% |
| Amounts payable after more than one year17 | €47,496 | €20,285 | €3,918 | €119,472 | €90,353 | ▼ 24.4% |
| Financial debts170/4 | - | €20,285 | €3,918 | €119,472 | €90,353 | ▼ 24.4% |
| Amounts payable within one year42/48 | €176,176 | €198,893 | €172,339 | €312,556 | €330,886 | ▲ 5.9% |
| Current portion of amounts payable after more than one year42 | - | €27,211 | €16,366 | €32,135 | €29,118 | ▼ 9.4% |
| Financial debts43 | - | €15,000 | €15,000 | €142 | €20,047 | ▲ 14,039% |
| Credit institutions430/8 | - | €15,000 | €15,000 | €142 | €20,047 | ▲ 14,039% |
| Trade debts44 | €9,669 | €8,082 | €7,063 | €5,317 | €5,414 | ▲ 1.8% |
| Suppliers440/4 | - | €8,082 | €7,063 | €5,317 | €5,414 | ▲ 1.8% |
| Taxes, remuneration and social security45 | - | €20,237 | €12,658 | €11,870 | €5,131 | ▼ 56.8% |
| Taxes450/3 | - | €12,250 | €10,273 | €7,388 | €1,480 | ▼ 80.0% |
| Remuneration and social security454/9 | - | €7,987 | €2,385 | €4,482 | €3,651 | ▼ 18.5% |
| Other amounts payable47/48 | - | €128,363 | €121,253 | €263,092 | €271,176 | ▲ 3.1% |
| Accrued charges and deferred income492/3 | - | - | €144 | €35,487 | €29,809 | ▼ 16.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €85,471 | €57,029 | €62,435 | €124,946 | €174,904 | ▲ 40.0% |
| + Depreciation and write-downs630 | €45,581 | €42,495 | €39,611 | €43,275 | €70,584 | ▲ 63.1% |
| Operating cash flow (approximation) | €131,053 | €99,524 | €102,045 | €168,221 | €245,488 | ▲ 45.9% |
| Investment in fixed assets (approximation) | - | -€21,132 | -€7,529 | -€159,552 | -€5,068 | ▲ 96.8% |
| Change in cash | - | -€8,387 | -€30,651 | -€26,005 | €91,724 | ▲ 453% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
06-01
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial
Highest result since 2019net €174,904 ▲40%
Operating result €241,523, net result €174,904, both a record.
28-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
26-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2022
22-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2021
21-12
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2020
23-12
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
30-06
Financial
Weakest financial yearnet €44,362 ▼28.5%
Net result drops to €44,362, the lowest in the series; recovery starts the following year.
30-06
Financial
Equity above €200,000Eq €229,894 ▲23.4%
2 profitable years in a row build equity to €229,894.
10-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
11-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Izegem · 1 establishment unit since 2017
Ground area
852 m²
Building footprint
483 m²
Volume, LiDAR
4,341 m³
2 parcels, Flanders · tallest building 12.4 m, ±4 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
CRISPINUS
since 20172.261.263.406
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 36494D1015/00L002 | Flanders | 533 m² | 1 · 196 m² | 11.2 m · 3 fl. |
| 36008A0645/00S003 | Flanders | 318 m² | 1 · 287 m² | 12.3 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
875500UYCDD3HBOSP346
Similar companies · same sector, comparable size
DR. VERMEIJ NEUROLOGIE
BE 0738.701.223
Heusden-Zolder · Eq €124,457
DOCTEUR SAVINE DEVOS
BE 0818.970.802
Binche · Eq €124,391
Corbacor
BE 0736.430.631
Kontich · Eq €124,368
Docteur Gizzi Marco - Oncomed
BE 0507.662.465
Gerpinnes · Eq €124,660
PHLEBEX
BE 0795.389.409
Beauraing · Eq €124,337
Of 16,627 companies in sector 86220 we hold annual accounts for 7,988. 6,593 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded03-02-2017
Fiscal year end30-06
Activities, NACEBEL 2025
86220Specialist medical practice
86995Nutrition and dietetics services
E-invoicing
Reachable via Peppol
Peppol ID
0208:0670736093
Also
9925:BE0670736093
Registered
09-03-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.